Listed

Cryo Cell International Inc: Form 10-Q for the period ended May 31, 2016

Filed with the SEC on Jul 11, 2016 and accepted by EDGAR at Jul 11, 2016, 21:29 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-05-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-03-01 to 2016-05-31$5.8mus-gaap:Revenues
Revenue6 months2015-12-01 to 2016-05-31$10.9mus-gaap:Revenues
Cost of revenue3 months2016-03-01 to 2016-05-31$1.4mus-gaap:CostOfServices
Cost of revenue6 months2015-12-01 to 2016-05-31$2.8mus-gaap:CostOfServices
Research and development3 months2016-03-01 to 2016-05-31$12.0kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2015-12-01 to 2016-05-31$20.7kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2016-03-01 to 2016-05-31$3.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2015-12-01 to 2016-05-31$7.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2016-03-01 to 2016-05-31$882.4kus-gaap:OperatingIncomeLoss
Operating income6 months2015-12-01 to 2016-05-31$1.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2016-03-01 to 2016-05-31$343.5kus-gaap:InterestExpense
Interest expense6 months2015-12-01 to 2016-05-31$604.8kus-gaap:InterestExpense
Income tax3 months2016-03-01 to 2016-05-31$201.7kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2015-12-01 to 2016-05-31$201.7kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-03-01 to 2016-05-31$637.1kus-gaap:NetIncomeLoss
Net income6 months2015-12-01 to 2016-05-31$514.2kus-gaap:NetIncomeLoss
Diluted EPS3 months2016-03-01 to 2016-05-31$0.07us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2015-12-01 to 2016-05-31$0.06us-gaap:EarningsPerShareDiluted
Basic EPS3 months2016-03-01 to 2016-05-31$0.07us-gaap:EarningsPerShareBasic
Basic EPS6 months2015-12-01 to 2016-05-31$0.06us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2016-03-01 to 2016-05-319,397,230 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2015-12-01 to 2016-05-319,336,538 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2015-12-01 to 2016-05-31$1.3mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure6 months2015-12-01 to 2016-05-31$292.2kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2015-12-01 to 2016-05-31$443.2kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2016-05-31$4.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-05-31$11.1mus-gaap:AssetsCurrent
Total assetsAt period end2016-05-31$20.5mus-gaap:Assets
Current liabilitiesAt period end2016-05-31$10.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-05-31$25.1mus-gaap:Liabilities
Long-term debtAt period end2016-05-31$2.3mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2016-05-31−$4.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-16-645605. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.